Post job

Novartis's revenue is $51.7 billion.

What is Novartis's revenue?

Novartis's annual revenue is $51.7B. Zippia's data science team found the following key financial metrics about Novartis after extensive research and analysis.
  • Novartis's revenue growth from 2023 to 2024 is 10.85%.
  • Novartis has 110,000 employees, and the revenue per employee ratio is $470,200.
  • Novartis peak revenue was $51.7B in 2024.
  • Novartis annual revenue for 2024 was 51.7B, 10.85% growth from 2023.

On this page

Peak revenue
$51.7B (2024)
Company peak revenue
Revenue / employee
$470,200
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$51.7B (2024)
Company peak revenue
Revenue / employee
$470,200
Company revenue / employee

Novartis financial information

CEOVasant Narasimhan
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number110,000
Date Founded1996
HeadquartersEast Hanover, New Jersey
Number of Locations29
Revenue$51.7B
Net IncomeUS$8.07 billion (2020) [2]
Gross Proft$38.9B (2024)
PE Ratio16.20
Tax Rate0.1%
Market Capitalization$193.5B
Total AssetsUS$132.06 billion (2020) [2]
TickerNVS

Novartis jobs you might like

Novartis competitors

Novartis's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Novartis's smallest competitor is Falcon Pharmaceuticals Ltd with revenue of $19.0M last year.

Novartis revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Novartis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Novartis. The employee data is based on information from people who have self-reported their past or current employments at Novartis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Novartis. The data presented on this page does not represent the view of Novartis and its employees or that of Zippia.

Novartis may also be known as or be related to Novartis, Novartis Corporation, Novartis US Foundation and Novartis Vaccines and Diagnostics, Inc.